Latest Announcements

GlaxoSmithKline Pharmaceuticals Limited has announced its Q1 FY27 financial results, with revenue up 15% YoY to INR 924 crores and PAT increasing by 24% to INR 253 crores. The company's General Medicines portfolio grew strongly, with key promoted brands outperforming the market. The company has also made progress in strengthening its supply chain resilience and is preparing for key pipeline launches.

Kansai Nerolac Paints Limited has informed the Exchange regarding a press release dated August 03, 2026, titled "Press Release for the unaudited financial results for the quarter ended 30th June, 2026." The Board of Directors of Kansai Nerolac Paints Limited has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026.

Ashok Leyland Ltd has scheduled a Board of Directors meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

TCPL Packaging Limited has scheduled a conference call on August 12, 2026, to discuss its Q1 FY2027 results, which will be declared on August 11, 2026.

Star Paper Mills Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the unaudited financial results for the quarter ended 30/06/2026.

GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the quarter ended June 30, 2026, along with changes in management and other business updates.

IL&FS Engineering and Construction Company Limited has published unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, and Hinduja Housing Finance Limited has taken possession of two properties due to non-payment of loans.

Octal Credit Capital Ltd has scheduled a board meeting on 12th August 2026 to consider and adopt unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.

Sumeru Industries Ltd has adopted a new corporate logo, which is a branding exercise and will not affect the company's legal status, name, constitution, business operations, or existing obligations.

Syrma SGS Technology Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as required by SEBI regulations.

Zuari Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2026.

Kaya Ltd's board meeting outcome: approved financial results for Q2 2026, appointed new company secretary, compliance officer, and senior management personnel, and deferred equity issuance plans.

Priya Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the Un-Audited Financial Results for the quarter ended on 30/06/2026.

Kansai Nerolac Paints Ltd's Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and the company's management is responsible for the preparation of the statement in accordance with Indian Accounting Standard 34.

IL&FS Engineering and Construction Company Ltd has published unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, in compliance with SEBI regulations.

Satiate Agri Ltd has announced the intimation of AGM, cut-off date/e-voting and book closure for the 39th Annual General Meeting. The meeting will be held on August 27, 2026, through video conferencing. The share transfer books and register of members will be closed from August 17 to August 27, 2026. The cut-off date for e-voting is August 20, 2026.

Siemens Energy India Ltd will hold a Board meeting on August 6, 2026, to consider the unaudited financial results for the third quarter and nine months ended June 30, 2026.

Computer Age Management Services Limited has informed the Exchange about Investor Presentation, presenting Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, with EBITDA growing 18.3% Y-o-Y to ₹183 Cr. and PAT growing 17.3% Y-o-Y to ₹128 Cr.

GlaxoSmithKline Pharmaceuticals Limited has presented its investor presentation, highlighting its Q1 FY27 financial performance, which saw revenue growth of 15% and EBITDA margin expansion of 50 bps, driven by execution excellence and portfolio transformation. The company's key brands maintained their competitive performance, and the vaccine segment continues to lead the market.

Madhya Bharat Agro Products Limited has informed the Exchange about Copy of Newspaper Publication regarding Extra-Ordinary General Meeting (EGM) and E-voting information.